VANGUARD GROUP INC 13D and 13G filings for Lyell Immunopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:04 pm Unchanged | 2024-09-30 | 13G | LYELL IMMUNOPHARMA INC LYEL | VANGUARD GROUP INC | 503,574 3.930% | 0 (Unchanged) | Filing |
| 2024-11-04 1:30 pm Sale | 2024-09-30 | 13G | LYELL IMMUNOPHARMA INC LYEL | VANGUARD GROUP INC | 503,574 3.930% | -176,627 (-25.97%) | Filing |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | LYELL IMMUNOPHARMA INC LYEL | VANGUARD GROUP INC | 680,201 5.400% | 50,639 (+8.04%) | Filing |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | LYELL IMMUNOPHARMA INC LYEL | VANGUARD GROUP INC | 629,562 5.050% | 629,562 (New Position) | Filing |